TILRAY BRANDS INC
TLRYNASDAQTrading Snapshot
- Day Range
- $2.62 β $2.77
- 52-Week Range
- $2.68 β $15.70
- Volume (shares)
- 4,345,228
- Avg Volume (shares)
- β
- Shares Outstanding
- 147.8M
- Next Earnings
- 2027-01-11
Fundamentals Snapshot
- Annual Revenue
- $915M
- Last Q Revenue
- $257M
- P/E Ratio
- β
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-1.39
- Dividend Yield
- β
- Dilution (1yr)
- +20.8%
TILRAY BRANDS INC
TLRYAbout TILRAY BRANDS INC
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?
Tilray's low valuation may be enticing to investors as its market cap is just $400 million. The business, however, struggles to grow organically on a consistent basis.

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.
Tilray started out as a pure-play marijuana company. The company has since decided to shift toward a consumer staples approach, selling branded products beyond pot.

Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
PATCHOGUE, N.Y., Oct. 22, 2026 (GLOBE NEWSWIRE) -- One of Long Island's longest-running craft beer celebrations is returning to Main Street.

West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), and West Ham

Tilray Brands (TSE:TLRY) Sets New 52-Week Low β Hereβs Why
Tilray Brands, Inc. (TSE: TLRY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday. The stock traded as low as C$4.61 and last traded at C$4.64, with a volume of 1,317,279 shares. T

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its revenue streams.